Kahlberg Andrea, Rinaldi Enrico, Piffaretti Gabriele, Speziale Francesco, Trimarchi Santi, Bonardelli Stefano, Melissano Germano, Chiesa Roberto
Vascular Surgery, Vita-Salute University School of Medicine, San Raffaele Scientific Institute, Milano, Italy.
Vascular Surgery, Vita-Salute University School of Medicine, San Raffaele Scientific Institute, Milano, Italy.
J Vasc Surg. 2016 Aug;64(2):313-320.e1. doi: 10.1016/j.jvs.2016.04.008. Epub 2016 Jun 9.
This study investigated the frequency, clinical features, therapeutic options, and results of aortoenteric fistulas (AEFs) developing after endovascular abdominal aortic repair (EVAR).
Eight Italian centers with an EVAR program participated in this retrospective multicenter study and collected data on AEFs that developed after a previous EVAR.
A total of 3932 patients underwent EVAR between 1997 and 2013 at the participating centers. During the same period, 32 patients presented with an AEF during EVAR follow-up, 21 with original EVAR performed for atherosclerotic aneurysmal disease (ATS group) and 11 with the original EVAR performed for a postsurgical pseudoaneurysm (PSA group). The incidence of AEF development after EVAR was 0.46% in the ATS group and 3.9% in the PSA group. Anastomotic PSA as the indication to EVAR (P < .0001) and urgent/emergency EVAR (P = .01) were significantly associated with AEF development. Median time between EVAR and the AEF diagnosis was 32 months (interquartile range, 11-75 months) for the ATS group and 14 months (interquartile range, 10.5-21.5 months) for the PSA group. Among five AEF patients treated conservatively, two (40%) died, at 7 and 15 months, and the remaining three were alive at a median follow-up of 12 months. The AEF was treated surgically in 27 patients, including aortic stent graft explantation in all cases, in situ aortic reconstruction in 14 (52%), and extra-anatomic bypass in 13 (48%). Perioperative mortality was 37% (10 of 27). No additional aortic-related death was recorded in operated-on patients at a median follow-up of 28 months.
Late AEFs rarely occur during EVAR follow-up, but the risk is significantly increased when EVAR is performed for PSA after previous aortic surgery and EVAR is performed as an emergency. Conservative and surgical treatment of post-EVAR AEF are both associated with high mortality. However, beyond the perioperative period, surgical correction of AEFs appears to be durable at midterm follow-up.
本研究调查了血管腔内腹主动脉修复术(EVAR)后发生的主动脉肠瘘(AEF)的发生率、临床特征、治疗选择及结果。
八个开展EVAR项目的意大利中心参与了这项回顾性多中心研究,收集了既往接受EVAR后发生AEF的数据。
1997年至2013年期间,参与研究的中心共有3932例患者接受了EVAR。同期,32例患者在EVAR随访期间出现AEF,其中21例最初因动脉粥样硬化性动脉瘤疾病接受EVAR(ATS组),11例最初因术后假性动脉瘤接受EVAR(PSA组)。EVAR后AEF的发生率在ATS组为0.46%,在PSA组为3.9%。以吻合口PSA作为EVAR的指征(P <.0001)和急诊/紧急EVAR(P =.01)与AEF的发生显著相关。ATS组从EVAR到AEF诊断的中位时间为32个月(四分位间距,11 - 75个月),PSA组为14个月(四分位间距,10.5 - 21.5个月)。在5例接受保守治疗的AEF患者中,2例(40%)分别在7个月和15个月时死亡,其余3例在中位随访12个月时存活。27例患者接受了手术治疗AEF,所有病例均包括取出主动脉支架移植物,14例(52%)进行了原位主动脉重建,13例(48%)进行了解剖外旁路手术。围手术期死亡率为37%(27例中的10例)。在中位随访28个月时,接受手术的患者未记录到额外的主动脉相关死亡。
晚期AEF在EVAR随访期间很少发生,但在既往主动脉手术后因PSA进行EVAR以及进行急诊EVAR时,风险会显著增加。EVAR后AEF的保守治疗和手术治疗均与高死亡率相关。然而,在围手术期之后,中期随访时AEF的手术矫正似乎效果持久。